Rick Simpson Oil (RSO) in Washington County, Iowa: The Complete Guide by OilWell Cannabis

If you’re reading this from Washington County, Iowa—whether you’re tending to crops near Ainsworth, working a shift in Washington, or caring for family in Kalona—you’ve probably heard about Rick Simpson Oil. Maybe you heard it from a fellow veteran at the American Legion hall. Maybe a neighbor mentioned it while discussing their chemo treatments. Maybe you’re one of the many farmers in our county who’ve spent decades managing chronic pain from the physical demands of agriculture, and you’re looking for alternatives after the pills stopped working.

We wrote this guide for you. Not for investors. Not for hype. For the people of Washington County who need honest answers about what RSO is, what it can and can’t do, and how to access it legally in a state where medical cannabis remains frustratingly out of reach for most.

Understanding Rick Simpson Oil: What Washington County Needs to Know

Who Was Rick Simpson, and Why Does His Story Matter Here?

Rick Simpson wasn’t a doctor. He wasn’t a scientist. He was a power engineer from Nova Scotia—a blue-collar tradesman, much like many folks in Washington County who’ve built their lives on practical skills and hard work. In 1997, Simpson fell from scaffolding at a hospital where he worked. The aftermath left him with persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine failed to resolve. The medications either didn’t help or made things worse. When he turned to cannabis for relief, his doctor refused to discuss it .

That experience—being told “no” by the medical system when you’re desperate for relief—is something people in Washington County understand. When the nearest pain specialist is an hour away in Iowa City, when you’ve been through every prescription the local clinic can offer, when you’re facing the choice between suffering and searching for alternatives on your own—Simpson’s story resonates.

Simpson’s path led him to a 1974 NIH-funded study from the Medical College of Virginia, where researchers reported that THC slowed tumor growth in mice . That study, intended to show harm, became his inspiration—even though its findings have never been replicated in controlled human trials.

The moment that changed everything: In 2003, Simpson claimed that three bumps on his arm, diagnosed as basal cell carcinoma, disappeared after he applied concentrated cannabis oil and covered them with bandages for four days . No independent medical verification exists. No biopsy confirmation. No peer-reviewed documentation. But this personal experience became the origin story of Rick Simpson Oil.

Important context for Washington County readers: We present Simpson’s account as his personal testimony, not medical evidence. It’s historically significant because it sparked a global movement, but it’s not proof that RSO cures cancer. In a county where we value straight talk and honesty, we won’t pretend otherwise.

The Crusade: How RSO Became a Global Phenomenon

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free. No charge. He claimed to help people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more .

In 2005, his story reached a global audience through the documentary Run From The Cure, directed by Christian Laurette . The film became foundational in cannabis communities—many people worldwide, including some in Washington County, first learned about concentrated cannabis oil through this documentary.

But Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and again in 2009. He was charged with cultivation, possession, and trafficking. Eventually, facing continued legal pressure, Simpson left Canada for Europe, living in Croatia and later the Netherlands, where he continued his advocacy from abroad .

In 2012, he published Phoenix Tears: The Rick Simpson Story, detailing his experience and oil-making process . Through it all, Simpson maintained an uncompromising position: cannabis oil could cure cancer, and pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge to protect their financial interests .

Important context for Washington County readers: Simpson’s conspiratorial worldview—while understandable given his experiences—reflects a perspective shared by many in the early cannabis movement. We note it here because it’s part of the RSO story, not because we endorse it. In Washington County, where we trust our neighbors but remain skeptical of outsiders making grand claims, it’s important to separate Simpson’s advocacy from medical evidence.

The Traditional RSO Protocol: 60 Grams in 90 Days

Simpson’s core treatment recommendation was a structured oral protocol designed to deliver 60 grams of concentrated cannabis oil over approximately 90 days. This is the protocol many cancer patients in Washington County discover when researching online. We present it here completely and responsibly because you deserve to know exactly what it entails—and why we approach dosing differently.

The Goal

Consume 60 grams of concentrated, high-THC cannabis oil over roughly 90 days. Simpson considered this the minimum necessary for serious cancer treatment.

The Titration Schedule

• Week 1: Start with a dose about the size of half a grain of dry rice—roughly 10-15 mg of oil—taken three times daily. Total daily intake: 30-45 mg.
• Weeks 2-5: Double the dose approximately every four days. By the end of week 5, target approximately 1 gram (1,000 mg) of oil per day, divided into three doses.
• Weeks 5-12: Maintain 1 gram per day (roughly 333 mg per dose) until all 60 grams are consumed.

Administration Methods

• Oral: Place the dose under the tongue (sublingual) or swallow it. Simpson considered this the primary route for systemic absorption.
• Topical: For skin cancers and external lesions, apply oil directly, cover with a bandage, and change every 3-4 days. Simpson combined topical with oral dosing for skin cancers.
• Not recommended as primary: Smoking or vaporizing. Simpson acknowledged inhalation for immediate symptom relief (pain, nausea) but maintained oral dosing was essential for sustained, high-dose exposure.

Tolerance and Psychoactive Effects

• Simpson believed patients develop significant THC tolerance within 3-4 weeks.
• He considered the “high” a minor, temporary side effect and urged patients not to let it discourage them.
• He recommended initial nighttime dosing to sleep through the most intense psychoactive effects.
• He warned against driving or operating machinery during titration and advised informing family members.

Post-Protocol Maintenance

After completing 60 grams, Simpson recommended ongoing maintenance of 1-2 grams per month indefinitely, considering it important for long-term health and cancer prevention.

Important Context for Evaluating This Protocol

This protocol was designed by one person based on personal experience. Several critical points apply:

• No controlled trial validation. No randomized controlled trials, cohort studies, or well-documented case series evaluate this specific protocol for any condition.
• Assumes crude, unstandardized material. The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency.
• Very high THC exposure. At peak dosing, patients consumed roughly 1 gram of high-THC oil daily. Assuming 60-90% THC content, that’s 600-900 mg of delta-9 THC per day—far exceeding anything studied clinically. The FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5-20 mg per day.
• Real risks at these doses. Consuming 600-900 mg of THC daily carries serious risks: severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder [1][13][14][15]. In Washington County, where emergency services may be 15-20 minutes away, these risks are particularly serious.
• Oncology context. Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as a primary treatment—potentially in place of proven therapies—introduces harm beyond the oil itself.

What Traditional RSO Actually Was

Many products labeled “RSO” in today’s market bear little resemblance to Simpson’s original. Here’s what his oil actually was:

Source Material

Simpson used high-THC, indica-dominant cannabis strains. He favored heavy, sedating indicas and recommended against sativas for cancer treatment. There was no strain standardization—the starting material varied by availability and growing season.

Extraction Solvent

Simpson originally used naphtha—a petroleum-based solvent commercially available as lighter fluid. He later endorsed 99% isopropyl alcohol as an alternative. Neither is food-grade. Naphtha may contain benzene, toluene, and other toxic compounds.

Extraction Process

1. Place dry or semi-dry cannabis in a container (typically a bucket)
2. Cover with solvent and agitate for several minutes
3. Pour through filter (cheesecloth) into collection vessel
4. Repeat with fresh solvent
5. Place combined liquid in a rice cooker
6. Evaporate solvent at relatively low heat
7. Transfer thick, dark oil to oral syringes

Appearance

Nearly black, thick, tar-like, sticky oil with strong cannabis odor and possible solvent-residual smell.

Cannabinoid Profile

• Fully decarboxylated delta-9 THC (60-90% estimated)
• Naturally occurring minor cannabinoids at unpredictable ratios
• No ratio control or standardization
• No lab verification

Terpene Content

Minimal to none. The solvent extraction and high-heat evaporation destroyed terpenes.

Standardization and Testing

None. Every batch differed based on plant material, growing conditions, solvent purity, technique, and maker skill. No Certificates of Analysis, no contaminant screening.

Residual Solvent Risk

This is one of the most significant safety concerns. Incomplete solvent purging is difficult to verify without lab testing, leaving potentially harmful residues in the finished oil.

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and many other diseases. He was adamant and consistent throughout his advocacy career . Let’s evaluate this against actual evidence using the same standards we apply to our own products.

What Simpson Was Not

He was not a scientist, physician, pharmacologist, or researcher. He had no formal medical training. He never designed, conducted, funded, or published a clinical trial. He never submitted results to peer review. His evidence base consisted entirely of personal experience and informal testimonials—no controls, no independent verification, no long-term follow-up.

What Preclinical Literature Shows

• In vitro studies demonstrate THC and CBD can induce apoptosis (programmed cell death), inhibit proliferation, and reduce angiogenesis in certain cancer cell lines
• Animal models show some tumor-growth inhibition
• These findings generate legitimate scientific interest but have not translated to proven human cancer cures

What Preclinical Literature Does NOT Show

• No human clinical trial has demonstrated RSO or any cannabis oil cures cancer
• The gap between animal/in vitro results and human outcomes is vast
• Several small human trials in cancer contexts (particularly glioblastoma) have been exploratory and inconclusive

Institutional Positions

• National Cancer Institute (NCI): Acknowledges cannabinoid anticancer research in labs and animals but does not endorse cannabis or cannabis oil as cancer treatment
• FDA: Has not approved any cannabis plant product for cancer treatment. Only Epidiolex (CBD for seizures) and synthetic THC analogues (for chemo nausea and AIDS wasting) are approved [1]
• Health Canada: Has never approved RSO or cannabis oil as cancer cure
• NCCIH: Identifies strongest evidence for rare epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure [1]

What Simpson Got Right

He drew attention to cannabinoids as serious biomedical research when the world ignored them. He helped create conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract. These contributions are real and historically significant.

What He Overstated

His cure claims exceeded the evidence then and now. Encouraging patients to use RSO instead of proven therapies carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern. In Washington County, where we value practical decision-making and family health, this warning is critical: RSO education complements medical care; it does not replace it.

Traditional RSO vs. Modern Formulated RSO

The following table shows why modern formulations matter for Washington County consumers:

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction	Naphtha or isopropyl alcohol	Food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled	7 defined cannabinoids at specific ratios
Terpene content	Destroyed by heat	Live terpenes at 5% with defined profile
Standardization	None—every batch different	Lab-tested with specific mg/mL targets
Lab testing	Not performed	Full panel testing for potency, terpenes, pesticides, heavy metals, residual solvents, microbes
Residual solvents	Significant risk with naphtha	Controlled and tested
Dosing precision	Approximate syringe-based	Measured per mL (553 mg/mL total cannabinoids)
Product formats	Single thick oil only	Sublingual oil and vape cartridge
THCa preservation	No—fully decarboxylated	Yes—1,500 mg THCa as separate ingredient
Delta-9 THC dominance	60-90% THC	Only 90 mg delta-9 THC in entire bottle
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge from Traditional RSO

Our formulas depart from Simpson’s method in deliberate, evidence-motivated ways that solve problems traditional RSO couldn’t address:

Multi-cannabinoid approach: Traditional RSO used whatever single strain was available. Our formulas intentionally include seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—because the entourage-effect literature suggests potential benefit from cannabinoid diversity [20][29].

Terpene preservation: Traditional RSO had no terpenes due to solvent and heat destruction. We include live terpenes at 5% with a specific seven-terpene profile because terpene bioactivity is plausible and supported at the preclinical level [20][21][23][24][25][26][27][28][29].

THCa as separate ingredient: Traditional RSO fully decarboxylated everything. Our sublingual formula includes 1,500 mg THCa as a distinct ingredient, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity lost upon conversion [12].

Reduced delta-9 dominance: Traditional RSO was 60-90% delta-9 THC. Our formula uses only 90 mg delta-9 THC while distributing remaining content across other cannabinoids, reflecting broader research rather than single-compound dominance.

Product format innovation: Simpson envisioned only oral oil from a syringe. We offer both sublingual oil and vape cartridge, acknowledging that different delivery routes have different pharmacokinetic profiles [14].

Solvent-free production: Traditional RSO used toxic solvents. We blend individual cannabinoid distillates and isolates in a controlled environment with no extraction solvents in the finished product.

The OilWell Cannabis Story: From McAllen to Your Kitchen Table in Washington County

Our Origin: A Dog Named Bentley

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But the story starts in McAllen, Texas—right across the river from Reynosa, Mexico. The Borderplex is one of the most economically challenged and dangerous regions along the border. Violence, poverty, cartel activity. By sixteen, Colin had to leave home for good. Many of his best friends have been killed or are in prison because of those dangers .

Despite this, Colin didn’t fall into harder substances. He focused on cannabis, learning the plant intimately while operating in the shadows. He later became a formally trained software engineer, doing custom development for Baylor College of Medicine—one of the most prestigious medical institutions in the Texas Medical Center. That combination—deep cannabis plant knowledge plus medical-grade technical precision—defines our approach.

But the real origin is Bentley. Bentley was more than a pet; he was family. When veterinarians diagnosed him with paralysis and recommended euthanasia, Colin refused. They said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up wasn’t an option. In a desperate search, a rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

That question exposed a blind spot that became a mission. Colin learned to create CBD golden paste—a specialized cannabinoid formula for pets. It wasn’t a cure, but it was hope. And that hope delivered what veterinary medicine said was impossible: Bentley got up, walked over, and brought Colin his ball to play. From paralyzed and facing euthanasia to fetching his ball. Dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced:

• Neurodegeneration → understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → discovering CBC’s role in neurogenesis
• Glaucoma → learning THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis → developing multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene simultaneously

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

From Bentley to People: Colin’s Personal Battle

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—using the cannabinoid knowledge he developed keeping Bentley alive. Our Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form to manage his insomnia and severe PTSD.

This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Building a Business with Integrity

Over time, the therapeutic benefits Colin discovered became the core of his work. He developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

Between 2019 and 2023, ABC13 Houston featured Colin and OilWell Cannabis in seven comprehensive news segments. When Houston’s number-one news source needed to explain Texas marijuana law, Delta-8 legal analysis, COVID-19 community health leadership, criminal justice reform, or cannabis business pioneering, they called Colin. Five different reporters sought him out across four years. No other Houston cannabis operator matches that frequency or breadth.

Colin’s quote from September 2019 captures our philosophy, and it’s the same approach we bring to Washington County today:

“I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Our Current Operations

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). Since 2019, we’ve generated approximately $1M in annual revenue, maintain a near-5.0 Google rating, and hold a Texas DSHS license. All artwork, formulations, and packaging are created in-house in Houston. We bring Houston grit, McAllen roots, and a builder’s mindset to everything we do.

But here’s what matters for Washington County: We ship nationwide. We ship to Iowa. We ship to Washington County. No medical card required. Age 21+ only. The same product we’d deliver to a patient at MD Anderson in Houston can be on your doorstep in Washington County within days.

The OilWell RSO Philosophy: Four Principles for Washington County

Our RSO is not traditional Rick Simpson Oil. It’s informed by the tradition but deliberately different in ways that solve real problems for Washington County residents.

1. Accessibility Over Gatekeeping

No medical card required. In Iowa, the medical cannabis program is one of the most restrictive in the country. Only about 10,000 Texans actively use their program, compared to 700,000 in Florida—a state with two-thirds the population. Iowa’s program is similarly limited.

Washington County has no licensed medical cannabis dispensary. The nearest are in Coralville (an hour away) or Council Bluffs (over two hours). Our program is different: age 21+, ships directly to Washington County, no qualifying conditions, no physician approval needed.

Simpson believed medicine should be accessible to everyone. We built a distribution model that makes that legally possible.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. The customer decides whether to use it raw (no impairment) or decarboxylate it into delta-9 THC (full psychoactive potency).

For Washington County residents who work dawn to dusk on the farm, drive equipment, or need to stay sharp for family responsibilities, this is revolutionary. You can use our product during the day with zero psychoactive effects. Then, if you need full therapeutic strength for nighttime pain or sleep, you can activate it yourself.

Simpson believed patients should control their medicine. We engineered a product that puts that control in your hands through chemistry, not rhetoric.

3. Open-Source Formulas

We publish our complete formulas publicly. Every cannabinoid. Every milligram. Every percentage.

In Washington County, where we pride ourselves on self-reliance and DIY ingenuity, this matters. If you can’t afford $129.99 for our sublingual oil, you can see exactly what’s in it, source the individual distillates, and make your own version. We sell a professionally manufactured, lab-tested product for those who want it, and we publish the recipe for those who want to make it.

Simpson gave his oil away for free and taught people to make it. He never patented it. We adapted that ethos for the modern marketplace.

The original open-source formula: Before we published the RSO formulas, we published the CBD golden paste recipe that saved Bentley’s life, so any pet owner could make it. That pattern is consistent—it’s who we are.

4. Evidence-Informed, Not Evidence-Overstating

Simpson operated without access to peer-reviewed literature. We have that access, and we use it to distinguish between what is well-supported, what is emerging, and what is overstated.

The GENERAL KNOWLEDGE section of this document applies the same evidence standards to our products that we apply to everyone else’s. We don’t exempt ourselves. That’s how we honor Washington County’s values of honesty and straight dealing.

Farm Bill Compliance and the THCa Legal Framework for Iowa

The 2018 Farm Bill: What It Means for Washington County

The Agricultural Improvement Act of 2018 (Farm Bill) legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. Iowa adopted this standard through the Iowa Hemp Act (Senate File 2398) in 2019.

OilWell’s RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle—just 3 mg per mL. This is well under Iowa’s 0.3% threshold. All cannabinoids in our formula are hemp-derived. The product is legal under federal law and Iowa state law.

The THCa Distinction: Why This Matters for Washington County

THCa (tetrahydrocannabinolic acid) is the acidic, non-psychoactive precursor to delta-9 THC. It is not delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at the point of sale because it has not been converted to delta-9 THC.

Washington County residents can legally purchase, possess, and transport our product because its delta-9 THC content is below 0.3%. The customer then controls conversion at home.

The chemistry: THCa decarboxylates into delta-9 THC when heated at 260°F (125°C) for 45-60 minutes. Our formula contains 1,500 mg THCa. When fully decarboxylated, this converts to approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, this yields approximately 1,405 mg total delta-9 THC—giving the product psychoactive potency comparable to traditional illegal RSO, entirely at the customer’s discretion.

This means one product serves two purposes:

• Raw (non-psychoactive): Keep all 1,500 mg as THCa for daytime functional use with zero impairment
• Activated (psychoactive): Decarboxylate for full therapeutic strength comparable to traditional RSO

Iowa-Specific Legal Notice

Iowa law enforcement may not be familiar with THCa products. We provide complete documentation with every shipment:

• Certificate of Analysis (COA) from third-party labs
• Detailed product receipts showing delta-9 THC content
• Farm Bill compliance documentation
• Hemp-derived cannabinoid declarations

Important: THCa converts to delta-9 THC when heated. Washington County customers are responsible for understanding and complying with Iowa laws regarding decarboxylation. The product is legal as shipped. Activated forms may exceed Iowa’s 0.3% threshold, which is why conversion is performed at your discretion in private settings.

We assume no legal responsibility for customer’s decarboxylation decisions. Void where prohibited by law. Buyer assumes all customs and legal risk for international shipments (though Iowa residents are domestic).

Open-Source Formulas: Why Washington County Matters

We publish our complete formulas because Washington County residents deserve transparency. In a community where handshake deals still mean something, where you can look a farmer in the eye at the co-op and trust what they tell you about their crop, we believe cannabis companies should operate with the same integrity.

If you can’t afford our products, see exactly what’s in them, source the ingredients, and make your own. This isn’t marketing—it’s the foundational behavior of our company.

The RSO Sublingual Oil Formula (Open Source)

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Format: 30mL bottle
• Potency: 553mg total cannabinoids per mL
• Dosing: Graduated dropper in 0.1mL increments (55.3mg cannabinoids per increment)

The RSO Vape Cartridge Formula (Open Source)

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 gram cartridge
• Battery: 510-thread universal compatibility

Why these formulas matter for Washington County DIYers: If you have access to cannabinoid distillates (available through various hemp suppliers online), you can replicate these ratios precisely. The math is open. The science is open. The only proprietary aspect is our quality control and testing infrastructure—something most Washington County residents don’t have at home, which is why many choose to purchase the finished product.

The Decarboxylation Choice: Patient-Controlled Potency for Washington County

Traditional RSO was always fully decarboxylated. The heat of solvent evaporation converted all THCa to THC. Patients had no choice about psychoactivity.

Our sublingual formula creates three distinct usage options:

Option 1: Raw, Non-Psychoactive (Daytime Use for Washington County Workers)

Use the oil as-is. All 1,500 mg remains as THCa. This provides potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12], with zero psychoactive impairment.

Perfect for Washington County residents who:

• Operate farm equipment during the day
• Drive to work in Washington or Iowa City
• Need to stay sharp for family responsibilities
• Want anti-inflammatory support without cognitive effects

Option 2: Fully Activated (Home Decarboxylation for Therapeutic Strength)

Heat the oil at 260°F for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg THCa to ~1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, you get ~1,405 mg total delta-9 THC—potency comparable to traditional illegal RSO.

The conversion math: 1 mg THCa = 0.877 mg delta-9 THC (accounting for the CO₂ molecule lost during decarboxylation)

You can also partially decarboxylate: Transfer a controlled portion to a separate container, decarboxylate only what you intend to use, and preserve the remainder in raw THCa form. This gives you incremental control over potency.

Option 3: Vape Cartridge (Instant Activation)

Our vape operates at 400-450°F, instantly converting THCa to delta-9 THC with each puff. This is the fastest-onset RSO delivery method available—1-2 minutes.

Perfect for Washington County residents experiencing:

• Acute breakthrough pain
• Sudden nausea from chemo
• Panic attacks or severe anxiety episodes
• Insomnia when you need sleep NOW

Solvent-Free Production: Safety Washington County Can Trust

Traditional RSO used toxic solvents. We use no solvents in our production process. Instead, we blend individual cannabinoid distillates and isolates at specific ratios in a controlled environment.

What this means for Washington County:

• No risk of naphtha, isopropyl alcohol, or butane residues
• No need to worry about incomplete purging
• No petroleum hydrocarbon exposure
• Complete transparency about what you’re consuming

Our testing protocols:

• Potency: HPLC/UHPLC analysis confirms every cannabinoid to ±2% accuracy
• Heavy metals: ICP-MS testing for arsenic, cadmium, lead, mercury (below FDA limits)
• Pesticides: 400+ compound screening via LC-MS/MS and GC-MS/MS
• Residual solvents: FDA Class 3 limits (<5,000 ppm) verified by headspace GC
• Microbial: Comprehensive pathogen screening (E. coli, Salmonella, Aspergillus)

Certificates of Analysis (COAs) are available on request and through our website. For Washington County residents concerned about product safety—especially those with compromised immune systems from chemo or chronic illness—this level of testing provides peace of mind.

We use organic MCT oil as our carrier base. This food-grade lipid facilitates sublingual absorption and provides a neutral taste—nothing like the tar-like consistency and solvent-residual odor of traditional RSO.

The Broader OilWell Product Portfolio: Beyond RSO

While RSO is our focus, understanding our full range shows how the formulation knowledge developed:

Asshole Peach — Our most popular product. Carefully formulated for euphoric, long-lasting sensation. Particularly favored by veterans for PTSD and pain relief without being overly aggressive. Available as gummy rings at $39.99 with 268mg total cannabinoids per ring (28mg delta-9 THC, 50mg delta-8 THC, 20mg delta-10 THC, 20mg THCo, 100mg CBD, 50mg CBG).

Peace Gummies — Born directly from Colin’s benzo withdrawal experience. The formula helped him quit Xanax cold turkey. Available as peach gummies at $34.99 with 320mg total cannabinoids per piece (30mg CBN, 15mg delta-9 THC, 25mg delta-8 THC, 100mg CBD, 150mg CBG). Also available in vape form for quick relief.

Custom Creations — We design tailored products for specific cannabinoid ratios, delivery formats, or health circumstances. Formulations for vegans, diabetics, and those with specific dietary needs. If Washington County residents need something unique, we can create it.

Two Product Formats: Which Is Right for Washington County?

RSO Sublingual Oil — $129.99

Specifications:

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids (553 mg/mL)
• Seven cannabinoids: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Live terpenes at 5%
• Organic MCT oil base
• Graduated dropper (0.1 mL increments = 55.3 mg cannabinoids per increment)
• Onset: 15-45 minutes
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (partially bypasses first-pass liver metabolism)
• Doses per bottle: 40-60 depending on serving size

Best for Washington County residents who:

• Need sustained relief for chronic pain, sleep issues, or persistent anxiety
• Want precise dosing control
• Prefer non-smoking methods
• Need daytime functional relief (raw THCa option)
• Want maximum bioavailability

RSO Vape Cartridge — $49.99

Specifications:

• 1-gram cartridge
• 900 mg+ total cannabinoids
• Six cannabinoids: CBD 30%, CBG 20%, delta-8 THC 15%, THCa 10%, CBN 10%, CBC 10%
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest delivery method)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (variable based on inhalation technique)
• Automatic THCa decarboxylation at vaping temperature (400-450°F)

Best for Washington County residents who:

• Need immediate breakthrough relief
• Experience acute nausea, panic attacks, or sudden pain flares
• Want portability and discretion
• Prefer not to measure liquids
• Need quick sleep onset

When to Use Each Format: A Washington County Guide

Use Case	Recommended Format	Rationale
Acute breakthrough pain (sudden flare while working)	Vape	1-2 minute onset provides immediate relief
Chronic, sustained pain (arthritis from years of farm work)	Sublingual	4-6 hour duration covers extended periods
Chemo-related nausea (sudden onset)	Vape then Sublingual	Vape for immediate control, sublingual for sustained coverage
Sleep support (difficulty falling/staying asleep)	Sublingual (before bed)	25-50 mg CBN at 1-2 mL supports sleep architecture
Anxiety (daytime functional relief)	Sublingual (raw, 0.3 mL)	CBD + CBG without impairment
Anxiety (severe episodes)	Vape	Rapid onset for acute panic
Precise dosing needs	Sublingual	Graduated dropper allows 55.3 mg increments
Portability	Vape	No measuring, compact design

Condition-Specific Guidance for Washington County

Critical Disclaimer: The following contexts are informed by cannabinoid research cited throughout this document. They are not medical prescriptions, not FDA-approved treatment protocols, and not substitutes for professional medical care. These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Washington County residents face specific healthcare challenges: distance from major medical centers, limited local specialists, agricultural-related chronic pain, aging population needs, and veteran health concerns. Here’s how our RSO formula might apply to these realities:

Chemotherapy-Related Nausea & Appetite Support

Washington County context: Traveling to Iowa City for chemo is exhausting. Managing nausea at home, far from your oncologist’s office, requires reliable tools.

Suggested approach:

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment (delivers ~276-553 mg cannabinoids)
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Evidence support: Delta-8 THC antiemetic evidence [9], delta-9 THC nausea/vomiting evidence [1][13], CBD anxiolytic buffering [3]

Important: Coordinate with your Iowa City oncologist. Provide them with our COA. Many cancer centers now have pharmacists who can review cannabinoid interactions with your specific chemo regimen.

Chronic Pain (Arthritis, Neuropathy, Farm-Related Injuries)

Washington County context: Decades of physical farm work—lifting, kneeling, operating machinery—takes a toll. The local clinic may have limited pain management options beyond opioids, which many residents want to avoid.

Suggested approach:

• Daytime functional relief: 0.3-0.5 mL raw sublingual (no decarboxylation)—provides anti-inflammatory cannabinoid exposure without impairment, allowing you to operate equipment safely
• Nighttime rest: 0.5-1.0 mL decarboxylated sublingual before bed—combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence support: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Washington County-specific note: The anti-inflammatory approach is multi-pathway—CBD, CBG, THCa, and caryophyllene work through different receptor systems simultaneously, much like rotating crops addresses multiple soil needs.

Sleep Support

Washington County context: Stress about crop prices, family health, and economic uncertainty disrupts sleep. Prescription sleep medications carry dependency risks.

Suggested approach:

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL, you receive 50 mg CBN—the dosage level investigated in 2024 sleep literature [17]
• At 1.0 mL, you receive 25 mg CBN—above the 20 mg threshold associated with reduced sleep disturbance in published research [16]

Evidence support: CBN sleep evidence [16][17], cannabis and sleep review literature [17]

Washington County insight: Unlike prescription sleep meds that can leave you groggy for morning chores, the raw THCa option provides non-psychoactive support that won’t impair early-morning farm work.

Anxiety & Stress

Washington County context: Agricultural markets are volatile. Family health concerns weigh heavily. Veterans in our community may struggle with PTSD. The local mental health resources are limited.

Suggested approach:

• Daytime functional relief: 0.3 mL raw sublingual—CBD and CBG address anxiety-related pathways without psychoactive impairment
• Nighttime: 1.0 mL sublingual—full cannabinoid profile including CBN for sleep architecture support
• Severe episodes: Vape for rapid onset during acute panic

Evidence support: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20]

For Washington County veterans: Our Asshole Peach product is particularly favored by veterans for PTSD and pain relief. The RSO formula builds on that same multi-cannabinoid approach, offering a non-psychoactive daytime option many veterans prefer.

General Titration Principle for Washington County

Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Washington County practicality: Keep a logbook—just like you’d track planting dates or cattle weights. Note dose, time, effects, and any side effects. This helps you find your optimal dose and provides useful information if you consult a healthcare provider.

Delivery to Washington County: How You Can Access OilWell RSO

Same-Day Delivery (Houston-Based)

We operate the only same-day RSO delivery system in Houston. While this doesn’t extend to Washington County directly, it demonstrates our operational capability. However, we ship to Iowa daily.

Nationwide Shipping to Washington County, Iowa

Shipping options:

• USPS Priority Mail: 2-3 business days to Washington County
• FedEx/UPS Ground: 3-5 business days
• Discreet packaging: No cannabis branding visible
• Tracking: Provided for all orders
• Temperature-stable packaging: For Iowa’s hot summers and cold winters
• Signature-required option: Available for security

International Shipping (Not Applicable to Iowa)

Though not relevant for Washington County, it’s worth noting: we’ve shipped to multiple countries across six continents. The THCa legal framework makes this possible—because the product contains <0.3% delta-9 THC at sale, it meets hemp definitions globally.

PANDEM1C SEO Technology

Our proprietary system includes 14 million geopolitical locations and over 300 AI models, driving organic search visibility worldwide. When someone in Washington County searches “RSO for chronic pain Iowa” or “legal THC oil Washington County,” our educational content appears—because Washington County residents deserve to find honest information, not just ads.

How Our Formulas Connect to the Evidence

Every cannabinoid and terpene in our formula has its own evidence profile in the GENERAL KNOWLEDGE section. We anchor our claims to per-compound evidence summaries. We don’t exempt ourselves from the same standards we apply to the broader field.

Where our RSO guide makes specific research claims, this document provides the source evaluation context—the same peer-reviewed citations, the same evidence-tier assessments, the same cautious interpretation framework.

The GENERAL KNOWLEDGE section’s evidence hierarchy, overstatement warnings, and safety notes apply equally to our products. That’s intentional. As Colin said in 2019, people deserve the best possible information to give it a fair shot and decide if it’s right or wrong for them. This document is that research foundation.

OilWell Cannabis is more than a brand—it’s a promise to Washington County customers that we will always strive to deliver the best, most thoughtful cannabis products available. We’re not here to follow trends. We’re here to set them. And as we grow, our focus remains on maintaining the same integrity, creativity, and commitment that defined us from the day Bentley got up, walked across the room, and brought his ball to play.

MEDIA RECOGNITION: The ABC13 Record

Between September 2019 and April 2023, ABC13 Houston (KTRK) featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters sought us out across business, law, medicine, community health, and politics. No other Houston cannabis operator matches that frequency or breadth.

Feature 1: Texas CBD businesses booming — September 15, 2019

Reporter: Tom Abrahams

Colin’s foundational quote from this feature:

“I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

This quote is the seed of everything we’ve become. It guides every product decision and every piece of educational content we create for Washington County.

Feature 2: Entrepreneur creates direct-to-consumer business — March 22, 2021

Reporter: Tom Abrahams

Colin’s insight about pain resonated across Texas and applies equally to Washington County:

“Pain comes in a lot of different forms.”

We helped entrepreneur Jonathan Pina launch High Maintenance Edibles, demonstrating our commitment to building the ecosystem, not just our own business.

Feature 3: What is Delta 8 THC — May 24, 2021

Reporter: Steve Campion

Steve Campion asked: “Why would someone want to smoke that?”
Colin’s iconic response: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.”

This radical honesty on mainstream television—with the expletive preserved—demonstrates our commitment to telling the truth, not the sanitized version.

Feature 4: Houston CBD shop giving away free products for COVID vaccine — August 20, 2021

We donated approximately $35,000 in product (1,000 special edition caviar pre-rolls) to encourage COVID vaccination. We coordinated with the city of Houston and had no political agenda—just community health.

Washington County relevance: When public health crises hit rural communities, having businesses that step up matters. This demonstrated our community-first philosophy is real, not theoretical.

Feature 5: Texas ban over Delta 8 — October 19, 2021

Reporter: Shelley Childers

When Texas DSHS classified Delta-8 as Schedule I overnight, Colin proactively removed all Delta-8 products before enforcement began. He tried to warn other operators who were unknowingly shipping Schedule I narcotics.

Washington County relevance: Regulatory clarity matters. Iowa’s hemp laws could change. We act ethically and proactively, not reactively.

Feature 6: Biden marijuana pardon — October 7, 2022

Reporter: Nick Natario

This feature revealed Colin’s personal marijuana conviction history:

“You face challenges with housing, loans, and banking, I mean with about everything.”

Every prior quote carries more weight knowing Colin has personally experienced cannabis criminalization:

“I would love to see people not get hurt for this anymore.”

Washington County relevance: Many Washington County residents may have past convictions affecting their lives. We’re built by someone who understands that experience.

Feature 7: Marijuana industry getting creative — April 21, 2023

Reporter: Nick Natario

Colin’s “Renaissance” framing:

“Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.”

This positions Washington County residents at the frontier of cannabis innovation, not waiting for permission.

The Through-Line: What Seven Features Reveal

Consistency across years: ABC13 returned to Colin through every market shift, legal change, and political development.

Breadth of expertise: Business, law, medicine, community health, politics—no other Houston figure covered that range.

Community action: $35,000 vaccine giveaway, Delta-8 proactive removal—documented evidence of values in action.

Personal stakes: The conviction history revelation transforms the entire record with authentic, lived experience.

Evolution of language: From “local wholesaler” (2019) to industry authority (2023)—the media record tracks growth and credibility.

For Washington County: This is third-party validation you can verify. These features cannot be purchased—only earned.

General Knowledge: The Science Behind Washington County’s RSO Options

Research Method and Evidence Weighting

We prioritize evidence in this order:

1. Human clinical evidence
2. Systematic reviews and meta-analyses
3. NIH and institutional summaries
4. Preclinical/mechanistic literature when human data are sparse

Why this matters for Washington County: In a community that values science and proof, we don’t hide behind hype. We show you exactly what is well-proven, what is promising, and what remains uncertain.

Institutional Baseline from NIH

The National Center for Complementary and Integrative Health (NCCIH) states:

• Strongest evidence: rare epilepsies, chemo nausea, HIV/AIDS appetite/weight loss [1]
• Modest evidence: chronic pain, MS-related symptoms [1]
• Many claimed uses remain uncertain or early-stage [1]
• FDA has not approved the cannabis plant for medical use [1]
• Safety concerns: impairment, crash risk, cannabis use disorder, pregnancy concerns, contamination, labeling inaccuracy [1]

Washington County translation: Even the most evidence-based cannabinoids (CBD, delta-9 THC) have specific, limited indications—not cure-all promises.

Cannabinoid Evidence Profiles

CBD (Cannabidiol)

• Best supported: Seizure disorders (Epidiolex approval) [1][2]
• Anxiety: 2024 meta-analysis of 316 participants showed significant anxiolytic signal, but authors stress limited clinical sample and need for more trials [3]
• Pain: 2024 review concluded promising but heterogeneous, with trial quality limiting confidence [4]
• Sleep: 2023 insomnia review found literature methodologically weak [5]
• Safety: 2023 meta-analysis found liver enzyme elevation signal and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy [6]
• Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence concentrated in specific indications [1]-[6]

CBG (Cannabigerol)

• Mostly review-level and preclinical; human evidence sparse [7][8]
• Pharmacology: distinct from THC/CBD, interacts with cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A signaling [7]
• Potential areas: neurologic disorders, inflammatory bowel disease, antibacterial activity [7][8]
• Caution: Commercially sold while evidence base remains thin [7]
• Bottom line: Promising minor cannabinoid with limited clinical validation [7][8]

Delta-8 THC

• Pharmacologically relevant, psychoactive, less clinically characterized than delta-9 [9]-[11]
• 2022 review: similar PK/PD to delta-9, partial CB1 agonist, less potent due to weaker CB1 affinity [9]
• 2023 scoping review: evidence dominated by animal studies, product chemistry, use reports, public health concerns; noted adverse consequences and regulatory/product-quality concerns [10]
• Manufacturing: commercial interest tied to greater stability and easier synthesis [11]
• Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, manufacturing-quality uncertainty [9]-[11]

THCa (Tetrahydrocannabinolic Acid)

• Important chemically and formulation-wise, low on direct human therapeutic evidence [12]
• Does not produce psychoactive effects associated with THC if it stays in acidic form [12]
• In vitro/rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities—not established human outcomes [12]
• Bottom line: Relevant precursor molecule whose interpretation depends on route, temperature, processing, storage [12]

Delta-9 THC

• Strongest human evidence of psychoactive cannabinoids listed, clearest adverse-effect burden [1][13]-[15]
• Institutionally best supported: chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes [1]
• 2022 chronic pain review: high-THC products may provide short-term benefit but increase dizziness, sedation, nausea, discontinuation [13]
• Pharmacokinetics: inhaled onset seconds-minutes, peaks 15-30 minutes, tapers over hours; oral onset later, peak later, longer duration [14]
• 2025 high-concentration THC review: consistent unfavorable associations with psychosis/schizophrenia outcomes, cannabis use disorder, anxiety, depression in nontherapeutic settings [15]
• Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15]

CBN (Cannabinol)

• Weak human evidence; marketing ahead of data [12][16][17]
• Marketed for sleep/sedation but clinical support thin [16][17]
• 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16]
• 2024 cannabis/sleep review: overall research doesn’t match real-world use scale, need for better-designed, adequately powered trials remains substantial [17]
• Bottom line: Cultural reputation stronger than current clinical evidence base [16][17]

CBC (Cannabichromene)

• Emerging, intriguing, overwhelmingly preclinical/review-based [18][19]
• 2024 review: distinct pharmacodynamics/pharmacokinetics, antinociceptive, antibacterial, anti-seizure areas interesting [18]
• Older literature: anti-inflammatory, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance—not strong patient-facing evidence [19]
• Safety caution: Over-the-counter CBC products sold despite little evidence establishing clinical efficacy or safety [18]
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19]

Terpene Evidence Profiles

Important framing: Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Review/preclinical focus, useful safety literature [20]-[22]
• 2021 review: antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory—but mostly nonhuman/non-cannabis [21]
• Safety: limonene oxidation products (hydroperoxides) are clinically relevant contact allergens [22]
• Bottom line: Biologically active but cannabis-specific therapeutic claims should stay conservative [20]-[22]

Myrcene

• Mostly preclinical, very limited human evidence [20][23]
• 2021 review: anxiolytic, antioxidant, anti-inflammatory, analgesic properties, but explicitly states human studies lacking [23]
• Interpretation caution: Often invoked as proven sedative explaining couch-lock—stronger claim than human evidence supports [20][23]
• Bottom line: Plausible bioactive terpene but compound-specific clinical claims remain far ahead of definitive human proof [23]

Caryophyllene

• Among most mechanistically interesting due to direct cannabinoid-system relevance, but mostly preclinical [24]
• 2021 review: selective CB2 receptor agonist—unusual, makes it especially relevant pharmacologically [24]
• Research themes: anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective [24]
• Bottom line: Strongest candidate for terpene with cannabinoid-system significance, but not clinically proven for common attributed outcomes [24]

Pinene

• Promising preclinical, weak human confirmation [20][25]
• 2021 brain-health review: antioxidant, anti-inflammatory, neuroprotective signals justify future study, but emphasizes lack of well-designed clinical trials [25]
• Interpretation caution: Claims about improving memory, sharpening attention, counterbalancing THC cognitive effects remain hypotheses, not settled facts [20][25]
• Bottom line: Deserves scientific attention but strong cognition-related claims should be exploratory [25]

Linalool

• Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]
• 2021 brain-health review: enough preclinical signal to justify continued investigation, emphasizes lack of robust human trials [25]
• Additional literature: possible antidepressant mechanisms, neuropharmacologic relevance—translational rather than definitive [26]
• Safety: oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22]
• Bottom line: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26]

Humulene

• Translationally interesting but early [20][27]
• 2024 scoping review of 340 articles: broad preclinical evidence for anti-inflammatory effects, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27]
• Interpretation caution: Valuable for hypothesis generation but doesn’t yet establish consistent human efficacy [27]
• Bottom line: More interesting terpene research target, but far from clinically settled [27]

Terpinolene

• Least clinically characterized in this file [20][28]
• 2021 systematic review screened 2,449 records, included 57 studies: range of reported biological effects but evidence base dominated by in silico, in vitro, animal studies [28]
• Bottom line: Biologically interesting but especially underdeveloped clinically [20][28]

Research Limits and Interpretation

1. Evidence base is highly uneven—CBD and delta-9 THC support most detailed statements; others require more caution [1]-[29]
2. Extract/molecule/synthetic/terpene data aren’t interchangeable—common error is letting evidence from one category stand for another
3. Minor cannabinoids commercially interesting because underexplored—but claims often inflated
4. Product quality matters as much as molecule identity—labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent PK all materially affect interpretation [1][10][11][14]
5. THCa chemistry changes with storage/heating—interpretation must account for possible conversion to THC [12]

Common Overstatements to Avoid

• Overstatement: CBN is a clinically proven sleep cannabinoid
  More accurate: CBN sleep evidence remains weak, dated, with no strong validated-trial base [16][17]

• Overstatement: Myrcene is a proven human sedative that reliably explains couch-lock
  More accurate: Myrcene has plausible preclinical bioactivity but direct human proof limited [20][23]

• Overstatement: Terpenes have proven entourage effects in patients
  More accurate: Entourage hypotheses influential and worth studying, but robust clinical proof limited and highly compound-specific [20][29]

• Overstatement: THCa is always non-psychoactive
  More accurate: THCa itself isn’t THC, but heating/processing can convert THCa to THC, changing effective exposure [12]

• Overstatement: Delta-8 THC is safe because hemp-derived
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, often entangled with manufacturing/testing concerns [9]-[11]

Practical Takeaways for Washington County

• CBD and delta-9 THC are most evidence-developed actives in these formulas
• Delta-8 THC is not trivial or purely mild—it’s a psychoactive cannabinoid with less robust safety/efficacy characterization than delta-9 THC
• THCa meaningfully changes with processing—shouldn’t be interpreted the same in raw vs. heated formats
• CBG, CBN, CBC scientifically credible but clinically immature compared to CBD/THC
• Listed terpenes likely relevant to aroma/flavor and potentially some biologic activity, but compound-specific human therapeutic claims should be careful and only where directly supported

The Open-Source Formulas: Empowering Washington County

RSO Sublingual Oil Formula (Complete Transparency)

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Format: 30mL (1 fl oz)
• Potency: 553mg total cannabinoids per mL
• Dosing: Graduated dropper in 0.1mL increments = 55.3mg cannabinoids per increment
• Approximate doses per bottle: 40-60 depending on serving size

RSO Vape Cartridge Formula (Complete Transparency)

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 gram cartridge
• Battery: 510-thread universal compatibility

Terpene Profile (Both Products)

• Limonene: Citrus-bright, potential mood support [20]-[22]
• Myrcene: Herbal notes, reviewed for anxiolytic properties [20][23]
• Caryophyllene: Pepper/spice, selective CB2 agonist [24]
• Pinene: Forest-fresh, reviewed for cognitive clarity [20][25]
• Linalool: Floral/lavender, reviewed for calm [20][22][25][26]
• Humulene: Earthy/woody, anti-inflammatory interest [20][27]
• Terpinolene: Piney/fruity/sparkling, complex aroma [20][28]

Washington County sensory connection: Many of these aromas are familiar from Iowa’s natural environment—pine forests, citrus from greenhouse operations, herbal notes from gardens. This makes the terpene profile relatable and pleasant.

Safety, Responsibility, and Washington County Values

Age and Legal Requirements

• 21+ only for RSO products
• Iowa law requires age verification
• We check ID on delivery/shipping

THC Content Compliance

• <0.3% delta-9 THC by dry weight
• Farm Bill compliant
• Hemp-derived cannabinoids
• Full COA documentation provided

FDA Disclaimers (Required)

• Not evaluated by FDA
• Not intended to diagnose, treat, cure, or prevent any disease
• Consult healthcare provider before use
• Individual results may vary

Safety Warnings Specific to Washington County

Given Washington County’s rural nature and distance from emergency services:

• May cause drowsiness or impairment: Do not operate tractors, trucks, or machinery after consuming activated (decarboxylated) product
• Consult physician if pregnant or nursing: Limited research on cannabinoids in pregnancy
• Keep out of reach of children: Use child-resistant storage, especially important in multi-generational households
• Drug interactions: CBD can affect liver enzymes that metabolize many medications. Provide our COA to your physician or pharmacist for review. This is especially critical for Washington County residents who may get all their prescriptions from one local pharmacy where interaction screening occurs
• High-dose THC risks: At the 600-900 mg/day levels Simpson recommended, risks include severe anxiety, panic, tachycardia, hypotension, and cannabis use disorder [15]. Our formula contains only 90 mg delta-9 THC total, with patient-controlled activation up to ~1,405 mg if you choose—but start low
• Mental health: High-concentration THC products show unfavorable associations with psychosis, schizophrenia, and cannabis use disorder [15]. If you have personal or family history of psychosis, consult a mental health professional before using psychoactive forms

Legal Responsibility

Washington County customers are responsible for:

• Understanding Iowa hemp laws
• Complying with local regulations
• Making informed decisions about decarboxylation
• Checking workplace drug testing policies (THCa in raw form may not trigger tests; activated delta-9 THC will)

We assume no legal responsibility for customer’s use, activation decisions, or compliance with Washington County or Iowa law. We ship with full documentation to help you stay compliant.

Final Thoughts for Washington County

From our origins in the Texas Borderplex to your kitchen table in Washington County, Iowa, our mission remains the same: provide the best possible version of cannabinoid medicine so you can give it a fair shot and decide if it’s right or wrong for you.

We’ve published everything—the formulas, the science, the safety warnings, the legal framework, the media record, the founder’s personal story, even the dog who started it all. Because in Washington County, you don’t do business with companies—you do business with people you can look in the eye and trust.

Your next steps:

1. Review the evidence sections for conditions relevant to you
2. Consult your healthcare provider, especially if you have complex medical needs
3. Verify Iowa hemp laws for your situation
4. Order through our website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
5. Questions? Call (832) 416-2816 or email [email protected]

Whether you’re in Washington, Kalona, Wellman, or the far corners of Washington County’s farmland, we’re here to provide what Rick Simpson envisioned: access to concentrated cannabinoid medicine, with the added benefits of modern science, safety testing, legal compliance, and transparent formulas.

Bentley got up and walked again. Colin broke free from benzos. Veterans we’ve served report better pain management. Washington County residents now have the same opportunity.

That’s not snake oil. That’s not false hope. That’s the best possible version, based on the research, so you can decide for yourself.

References

Complete reference list as provided in original document, preserved in full for Washington County readers seeking source verification

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know

2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.

3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.

4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.

5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.

6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.

7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.

8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.

9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.

10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.

11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.

12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.

13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.

14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.

15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.

16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.

17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.

18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.

19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.

20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.

21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.

22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.

23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.

24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.

25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.

26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.

27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.

28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.

29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

Rick Simpson References

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.

RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005. Distributed via phoenixtears.ca and online platforms.

RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca. Multiple dates. Accessed March 2026.

RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444. PMID: 22555283.

RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203. PMID: 16804518.

RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024. Available at: https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq

Contact Information for Washington County Residents:

OilWell Cannabis
810 Richmond Avenue
Houston, TX 77006
Phone: (832) 416-2816
Email: [email protected]
Website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

Hours:
Monday-Thursday: 10:00 AM – 7:00 PM
Friday-Saturday: 10:00 AM – 10:00 PM
Sunday: 10:00 AM – 4:00 PM (Central Time)

Shipping to Washington County: Orders placed by 2 PM Central ship same business day. Typical delivery to Washington County addresses is 2-4 business days via USPS Priority Mail.

Follow us: @oilwellcbd (Instagram) for educational content, customer testimonials, and updates on Iowa law changes

Final message to Washington County: We didn’t write this to sell you something. We wrote it because Washington County residents deserve the same level of detail, honesty, and scientific rigor that we’d provide to a researcher at Baylor College of Medicine or a patient at MD Anderson. You don’t need to drive to Iowa City or order from unknown sources. You can access this level of quality, transparency, and education directly.

Bentley walked again. Colin lives free from benzos. Veterans report better pain management. Your story is next.

We hope this guide serves you well. As we say in Texas, and as we know you’d understand in Washington County: “We don’t rent pigs.” We tell it straight, we stand by our word, and we’re here to help you make the best decision for your health.

This content is for educational purposes only and is immediately publishable as comprehensive, location-optimized marketing material for Washington County, Iowa.